全球癌症幹細胞市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計癌症幹細胞市場將從 2025 年的 22.6 億美元成長到 2034 年的 55.3 億美元，2026 年至 2034 年的複合年成長率為 10.43%。

全球癌症幹細胞（CSC）市場正快速崛起，成為腫瘤學研究的關鍵領域。癌症幹細胞被認為與腫瘤的發生和發展、轉移和復發密切相關，因此是下一代治療方法研發的關鍵方向。製藥和生物技術公司正大力投資於標靶CSC的藥物研發，而研究機構則利用專門的細胞株和檢測方法進行實驗檢驗。

單細胞定序、3D腫瘤模型和類器官培養系統等技術進步正在增強研究能力。越來越多的臨床試驗評估了標靶治療，從而擴大了商業性前景。全球癌症發生率的上升進一步加劇了對先進治療方案的需求。

未來市場成長取決於基於癌症幹細胞（CSC）的治療方法和伴隨診斷工具的臨床檢驗。整合CSC生物標記的精準醫療策略將提高治療效果。學術研究人員與製藥公司之間的合作將加速轉化研究的進展，並將CSC研究確立為現代腫瘤學創新核心支柱。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球癌症幹細胞市場：依癌症類型分類

• 市場分析、洞察與預測
• 乳癌
• 血
• 肺
• 腦
• 冒號
• 胰臟
• 膀胱
• 肝
• 其他

第5章 全球癌症幹細胞市場：依應用領域分類

• 市場分析、洞察與預測
• 標靶癌症幹細胞
• 利用幹細胞治療癌症

第6章 全球癌症幹細胞市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Merck KGaA
  • Miltenyi Biotec
  • Bionomics
  • AbbVie Inc
  • Stemline Therapeutics Inc
  • Thermo Fisher Scientific Inc
  • MacroGenics Inc
  • STEMCELL Technologies Inc
  • FUJIFILM Irvine Scientific
  • Lineage Cell Therapeutics Inc

The Cancer Stem Cell Market size is expected to reach USD 5.53 Billion in 2034 from USD 2.26 Billion (2025) growing at a CAGR of 10.43% during 2026-2034.

The global cancer stem cell (CSC) market is emerging as a critical segment within oncology research. Cancer stem cells are believed to contribute to tumor initiation, metastasis, and recurrence, making them a key focus area in next-generation therapeutic development. Pharmaceutical and biotech companies are investing heavily in CSC-targeted drug discovery, while research institutions utilize specialized cell lines and assays for experimental validation.

Technological advancements such as single-cell sequencing, 3D tumor models, and organoid culture systems are strengthening research capabilities. Increasing clinical trials evaluating CSC-targeted therapies are broadening commercial prospects. Rising cancer incidence globally further amplifies demand for advanced treatment solutions.

Future market growth will depend on clinical validation of CSC-based therapies and companion diagnostic tools. Precision medicine strategies integrating CSC biomarkers will enhance treatment efficacy. Collaborations between academic researchers and pharmaceutical firms will accelerate translational progress, positioning CSC research as a central pillar of modern oncology innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Cancer Forms

• Breast
• Blood
• Lung
• Brain
• Colorectal
• Pancreatic
• Bladder
• Liver
• Others

By Application

• Targeted Cancerous Stem Cells
• Stem Cell-based Cancer Therapy

COMPANIES PROFILED

• Merck KGaA, Miltenyi Biotec, Bionomics, AbbVie Inc, Stemline Therapeutics Inc, Thermo Fisher Scientific Inc, MacroGenics Inc, STEMCELL Technologies Inc, FUJIFILM Irvine Scientific, Lineage Cell Therapeutics Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CANCER STEM CELL MARKET: BY CANCER FORMS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Cancer Forms
• 4.2. Breast Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Lung Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Brain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Colorectal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Pancreatic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Bladder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Liver Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CANCER STEM CELL MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Targeted Cancerous Stem Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Stem Cell-based Cancer Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CANCER STEM CELL MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Cancer Forms
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Cancer Forms
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Cancer Forms
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Cancer Forms
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Cancer Forms
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CANCER STEM CELL INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Merck KGaA
  • 8.2.2 Miltenyi Biotec
  • 8.2.3 Bionomics
  • 8.2.4 AbbVie Inc
  • 8.2.5 Stemline Therapeutics Inc
  • 8.2.6 Thermo Fisher Scientific Inc
  • 8.2.7 MacroGenics Inc
  • 8.2.8 STEMCELL Technologies Inc
  • 8.2.9 FUJIFILM Irvine Scientific
  • 8.2.10 Lineage Cell Therapeutics Inc